The role of triphasic levonorgestrel in oral contraception: a review of metabolic and hemostatic effects

References

• Consensus Development Meeting. Metabolic aspects of oral contraceptives of relevance for cardiovascular disease. Am. J. Obstet. Gynecol. 1990; 162: 1335–7
   Google Scholar
• Porter J. B., Hunter J. R., Danielson D. A., Jick H., Stergachis A. Oral contraceptives and nonfatal vascular disease: recent experience. Obstet. Gynecol. 1982; 59: 299–302
   PubMed Web of Science ®Google Scholar
• World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case—control study. Lancet 1995; 346: 1575–82
   PubMed Web of Science ®Google Scholar
• Baggett B., Nash H. A. Effects of contraceptive steroids on serum lipoproteins and cardiovascular disease scrutinized at workshop in Bethesda. Contraception 1980; 21: 115–20
   PubMed Web of Science ®Google Scholar
• Zimmer F., Riebeling V., Benke B., Schuster J., Roskamm H. The LDL: HDL ratio in patients with coronary arteriosclerosis. Z. Kardiol 1980; 69: 149–53
   Google Scholar
• Hoppe G. Oral contraceptive-induced changes in plasma lipids: do they have any clinical relevance. Clin. Reprod. Fertil 1987; 5: 333–45
   Google Scholar
• Fotherby K. Oral contraceptives and lipids. Br. Med. J. 1989; 298: 1049–50
   PubMed Web of Science ®Google Scholar
• Fotherby K. Oral contraceptives, lipids and cardiovascular disease. Contraception 1985; 31: 367–94
   PubMed Web of Science ®Google Scholar
• Fotherby K. Effect of oral contraceptives on serum apoprotein levels. Adv. Contracept. 1986; 2: 65–9
   Google Scholar
• Godsland I. F., Crook D., Simpson R., Proudler A., Felton C., Lees B., Anyaoku V., Devenport M., Wynn V. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism. N. Engl. J. Med. 1990; 323: 1375–81
   PubMed Web of Science ®Google Scholar
• Prasad R. N. F., Liew D., Ratnam S. S. Comparative metabolic effects of three types of combined oral contraceptive pills in Chinese women. Contraception 1989; 39: 21–35
   PubMed Web of Science ®Google Scholar
• Patsch W., Brown S. A., Gotto A. M., Young R. L. The effect of triphasic oral contraceptives on plasma lipids and lipoproteins. Am.]. Obstet. Gynecol. 1989; 161: 1396–401
   Google Scholar
• Notelovitz M., Feldman E. B., Gillespy M., Gudat J. Lipid and lipoprotein changes in women taking low-dose triphasic contraceptives: a controlled, comparative, 12-month clinical trial. Am. J. Obstet. Gynecol. 1989; 160: 1269–80
   PubMed Web of Science ®Google Scholar
• Lepot M. R., Gaspard U. J. Metabolic effects of two low-dose triphasic oral contraceptives containing ethinyl estradiol and levonorgestrel or gestodene. Int. J. Fertil. 1987; 32: 15–20, Suppl
   PubMedGoogle Scholar
• Kjær A., Lebech A.-M., Borggaard B., Refn H., Pedersen L. R., Schierup L., Bremmelgaard A. Lipid metabolism and coagulation of two contraceptives: correlation to serum concentrations of levonorgestrel and gestodene. Contraception 1989; 40: 665–73
   Google Scholar
• Kauppmen-Mäkelin R., Kuusi T., Ylikorkala O., Tikkanen M. J. Contraceptives containing desogestrel or levonorgestrel have different effects on serum lipoproteins and post-heparin plasma lipase activities. Clin. Endocrinol. 1992; 36: 203–9
   Google Scholar
• Janaud A., Rouffy J., Upmalis D., Dain M.-P. A comparison study of lipid and androgen metabolism with triphasic oral contraceptive formulations containing norgestimate or levonorgestrel. Acta Obstet. Gynecol. Scand. 1992; 71: 33–8, Suppl. 156
   Web of Science ®Google Scholar
• Harvengt C., Desager J. P., Gaspard U., Lepot M. Changes in lipoprotein composition in women receiving two low-dose oral contraceptives containing ethinylestradiol and gonane progestins. Contraception 1988; 37: 565–75
   Google Scholar
• Gaspard U. J., Buret J., Gillain D., Rohus H. A., Lahbotte R. Serum lipid and lipoprotein changes induced by new oral contraceptives containing ethinylestradiol plus levonorgestrel or desogestrel. Contraception 1985; 31: 395–408
   PubMed Web of Science ®Google Scholar
• Ball M. J., Ashwell E., Jackson M. C., Gillmer M. D. G. Comparison of two triphasic contraceptives with different progestogens: effects on metabolism and coagulation proteins. Contraception 1990; 41: 363–76
   Google Scholar
• Ball M. J., Ashwell E., Jackson M. C., Carter R., Gillmer M. D. G. Which pill? The effect of various modern preparations on lipoproteins and glucose metabolism. Br. J. Family Planning 1989; 14: 110–15
   Google Scholar
• Wiik P., Nordby J., Paulsen J. E. Effect of norethisterone and levonorgestrel in low-dose multiphasic oral contraceptives on serum lipids. Acta Obstet. Gynecol. Scand. 1993; 72: 550–5
   Web of Science ®Google Scholar
• Kjos S. L., Shoupe D., Douyan S., Friedman R. L., Bernstein G. S., Mestman J. H., Mishell D. R. Effect of low-dose oral contraceptives on carbohydrate and lipid metabolism in women with recent gestational diabetes: results of a controlled, randomized, prospective study. Am. J. Obstet. Gynecol. 1990; 163: 1822–7
   PubMed Web of Science ®Google Scholar
• Kakis G., Powell M., Marshall A., Steiner G. A randomized comparative open study of the effect of two oral contraceptives, Triphasil and Ortho 7/7/7, on lipid metabolism. Contraception 1993; 47: 131–48
   Google Scholar
• Fotherby K. Effect of oral contraceptives on serum lipids and cardiovascular disease. Br. J. Family Planning 1985; 11: 86–91
   Google Scholar
• Avogaro P., Bittolo Bon G., Cazzelato G., Quinci G. B. Are lipoproteins better discriminators than lipids for atherosclerosis. Lancet 1979; 1: 901–3
   PubMed Web of Science ®Google Scholar
• Loke D. F. M., Ng C. S. A., Samsioe G., Hoick S., Ratnam S. S. A comparative study of the effects of a monophasic and a triphasic oral contraceptive containing ethinyl estradiol and levonorgestrel on lipid and lipoprotein metabolism. Contraception 1990; 42: 535–54
   Google Scholar
• Spellacy W. N. Carbohydrate metabolism during treatment with estrogen, progestogen and low-dose oral contraceptives. Am. J. Obstet. Gynecol. 1982; 142: 732–4
   PubMed Web of Science ®Google Scholar
• Harvengt C. Effect of oral contraceptive use on the incidence of impaired glucose tolerance and diabetes mellitus. Diabete Metab. 1992; 18: 71–7
   Google Scholar
• Vander Vange N. K., Loosterboer H. J., Haspels A. A. Effect of seven low-dose combined oral contraceptives preparations on carbohydrate metabolism. Am. J. Obstet. Gynecol. 1987; 156: 918–22
   Google Scholar
• Spellacy W. N., Ellingson A. B., Tsibris J. C. M. The effects of two triphasic oral contraceptives on carbohydrate metabolism in women during 1 year of use. Fertil. Steril. 1989; 51: 71–4
   Google Scholar
• Luyckx A. S., Gaspard U. J., Romus M. A., Grigorescu F., De Meyts P., Lefebvre P. J. Carbohydrate metabolism in women who used oral contraceptives containing levonorgestrel or desogestrel: a 6-month prospective study. Fertil. Steril 1986; 45: 635–42
   PubMed Web of Science ®Google Scholar
• Irsigler K., Grabner E., Regal H. Metabolische Wirkungen eines Dreistufenkontrazeptivums. Aktuelle Aspekte der Hormonalen Kontrazeption, J. Hammerstein. Excerpta Medica, Amsterdam 1982; 65
   Google Scholar
• Vermeulen A., Thiery M. Metabolic effects of the triphasic oral contraceptive Trigynon. Contraception 1982; 26: 505–13
   PubMed Web of Science ®Google Scholar
• Skouby S. O. Effect of oral contraceptives on carbohydrate metabolism in healthy women. Female Contraception: Update and Trends, B. Runnebaum, T. Rabe, L. Kiesel. Springer-Verlag, Berlin 1988; 60–3
   Google Scholar
• Gaspard U. J., Lefebvre P. J. Clinical aspects of the relationship between oral contraceptives, abnormalities in carbohydrate metabolism, and the development of cardiovascular disease. Am. J. Obstet. Gynecol. 1990; 163: 334–43
   PubMed Web of Science ®Google Scholar
• Bonnar J., Sabra A. Comparative data on the effects of low-dose oral contraceptives on coagulation. Update on Triphasic Oral Contraception, M. Elstein. Parthenon Publishing, CarnforthUK 1982; 9–21
   Google Scholar
• Bruni V., Rosati S., Bucciantini S., Verni A., Abbate R., Pinto S., Costanzo G., Costanzo M. Platelet and coagulation functions during triphasic oestrogen—progestogen treatment. Contraception 1986; 33: 39–46
   Google Scholar
• Bonnar J., Daly L., Carroll E. Blood coagulation with a combined pill containing gestodene and ethinyl estradiol. Int. J. Fertil. 1987; 32: 21–8, Suppl.
   PubMedGoogle Scholar
• Prasad R. N. V., Koh S., Ratnam S. S. Effects of three types of combined OC pills on blood coagulation, fibrinolysis and platelet function. Contraception 1989; 39: 369–83
   Google Scholar
• Melis G. B., Fruzzetti F., Nicoletti I., Ricci C., Lammers P., Atsma W. J., Fioretti P. A comparative study on the effects of a monophasic pill containing desogestrel plus 20 μg ethinylestradiol, a triphasic combination containing levonorgestrel and a monophasic combination containing gestodene on coagulatory factors. Contraception 1991; 43: 23–31
   PubMed Web of Science ®Google Scholar
• Cohen H., Mackie I. J., Walshe K., Gülmer M. D. G., Machin S. J. A comparison of the effects of two triphasic oral contraceptives on haemostasis. Br. J. Haematol. 1988; 69: 259–63
   Google Scholar
• Mammen E. F. Oral contraceptives and blood coagulation: a critical review. Am. J. Obstet. Gynecol. 1982; 142: 758–61
   Google Scholar
• Bonnar J., Daly L., Sabra A., Carroll E. Effects of oral contraception on blood clotting. Female Contraception: Update and Trends, B. Runnebaum, T. Rabe, L. Kiesel. Springer-Verlag, Berlin 1988; 56–9
   Google Scholar
• Rákóczi I., Gerö G., Demeter J., Gáti I. Comparative metabolic effects of oral contraceptive preparations containing different progestogens: effects of desogestrel + ethinylestradiol on haemostatic balance. Arzneim. Forsch./Drug Res. 1985; 35: 630–3
   Google Scholar
• Upton G. V. Lipids, cardiovascular disease, and oral contraceptives. Fertil. Steril. 1990; 53: 1–12
   PubMed Web of Science ®Google Scholar
• Croft P., Hannaford P. C. Risk factors for acute myocardial infarction in women: evidence from the Royal College of General Practitioners' oral contraceptive study. Br. Med. J. 1989; 298: 165–8
   PubMed Web of Science ®Google Scholar
• Wynn V., Godsland I., Simpson R., Lees B., Proudler T., Felton C., Anyoku V., Crook D. Carbohydrate and lipid metabolism in low-dose oral contraception. Advances in Gynecology and Obstetrics, Vol. 1: Fertility, Sterility and Contraception, P. Belfort, J. A. Pinotti, T. K. A. B. Eskes. Parthenon Publishing, CarnforthUK 1988; 287–98
   Google Scholar